KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) EBT (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 37.65%
Dec 31, 2025 -61.39%
Sep 30, 2025 150.06%
Jun 30, 2025 -20.53%
Mar 31, 2025 152.30%
Dec 31, 2024 -74.78%
Sep 30, 2024 290.55%
Jun 30, 2024 1,267.65%
Mar 31, 2024 -107.98%
Dec 31, 2023 -56.24%
Sep 30, 2023 20.63%
Jun 30, 2023 -53.11%
Mar 31, 2023 96.91%
Dec 31, 2022 -26.92%
Sep 30, 2022 56.24%
Jun 30, 2022 -8.60%
Mar 31, 2022 -21.40%
Dec 31, 2021 -1.11%
Sep 30, 2021 286.20%
Jun 30, 2021 -69.95%
Mar 31, 2021 -1.07%
Dec 31, 2020 -14.91%
Sep 30, 2020 8.67%
Jun 30, 2020 0.50%
Mar 31, 2020 1.87%
Dec 31, 2019 -12.91%
Sep 30, 2019 -11.19%
Jun 30, 2019 10.80%
Mar 31, 2019 5.90%
Dec 31, 2018 4.35%
Sep 30, 2018 -20.89%
Jun 30, 2018 1.07%
Mar 31, 2018 18.29%
Dec 31, 2017 -7.01%
Sep 30, 2017 -6.33%
Jun 30, 2017 3.33%
Mar 31, 2017 7.75%
Dec 31, 2016 -5.58%
Sep 30, 2016 9.71%
Jun 30, 2016 -2.39%
Mar 31, 2016 18.03%
Dec 31, 2015 -12.73%
Sep 30, 2015 9.76%
Jun 30, 2015 6.45%
Mar 31, 2015 45.88%
Dec 31, 2014 -3.81%
Sep 30, 2014 -23.95%
Jun 30, 2014 46.01%
Mar 31, 2014 18.74%
Dec 31, 2013 -32.53%
Sep 30, 2013 6.98%
Jun 30, 2013 4.62%
Mar 31, 2013 45.50%
Dec 31, 2012 -26.92%
Sep 30, 2012 -13.32%
Jun 30, 2012 6.66%
Mar 31, 2012 29.97%
Dec 31, 2011 131.50%
Sep 30, 2011 -66.09%
Jun 30, 2011 2.53%
Mar 31, 2011 30.73%
Dec 31, 2010 -30.33%
Sep 30, 2010 -2.05%
Jun 30, 2010 3.10%
Mar 31, 2010 32.09%
Dec 31, 2009 -30.19%
Sep 30, 2009 13.49%
Jun 30, 2009 10.15%